The estimated Net Worth of Jeff E. Knight is at least 5.84 百万$ dollars as of 15 July 2024. Mr Knight owns over 27,000 units of Crinetics Pharmaceuticals Inc stock worth over 2,620,873$ and over the last 3 years he sold CRNX stock worth over 2,985,101$. In addition, he makes 237,638$ as Chief Operating Officer at Crinetics Pharmaceuticals Inc.
Mr has made over 4 trades of the Crinetics Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 27,000 units of CRNX stock worth 1,485,000$ on 15 July 2024.
The largest trade he's ever made was selling 32,359 units of Crinetics Pharmaceuticals Inc stock on 22 March 2024 worth over 1,433,827$. On average, Mr trades about 6,147 units every 72 days since 2021. As of 15 July 2024 he still owns at least 51,653 units of Crinetics Pharmaceuticals Inc stock.
You can see the complete history of Mr Knight stock trades at the bottom of the page.
Jeff E. Knight is the Chief Operating Officer at Crinetics Pharmaceuticals Inc.
As the Chief Operating Officer of Crinetics Pharmaceuticals Inc, the total compensation of Mr Knight at Crinetics Pharmaceuticals Inc is 237,638$. There are 9 executives at Crinetics Pharmaceuticals Inc getting paid more, with R. Scott Struthers having the highest compensation of 3,766,660$.
Mr Knight is 50, he's been the Chief Operating Officer of Crinetics Pharmaceuticals Inc since . There are 15 older and 3 younger executives at Crinetics Pharmaceuticals Inc. The oldest executive at Crinetics Pharmaceuticals Inc is Wendall Wierenga, 72, who is the Independent Chairman of the Board.
Jeff's mailing address filed with the SEC is C/O CRINETICS PHARMACEUTICALS, INC., 6055 LUSK BOULEVARD, SAN DIEGO, CA, 92121.
Over the last 6 years, insiders at Crinetics Pharmaceuticals Inc have traded over 52,514,606$ worth of Crinetics Pharmaceuticals Inc stock and bought 3,613,259 units worth 62,800,483$ . The most active insiders traders include Advisors Llcperceptive Life...、Jack Nielsen、Capital Viii, Llc Vivo Capi.... On average, Crinetics Pharmaceuticals Inc executives and independent directors trade stock every 20 days with the average trade being worth of 3,116,248$. The most recent stock trade was executed by Stephen F. Betz on 26 August 2024, trading 3,000 units of CRNX stock currently worth 159,570$.
neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.
Crinetics Pharmaceuticals Inc executives and other stock owners filed with the SEC include: